Signalife, a Greenville, SC, firm specialized in biomedical signal monitoring, has hired a new distribution organization for its Fidelity 100 product line. The technology, originally developed to monitor brain waves of U.S. Air Force Pilots, compresses and reduces noise prior to amplifying an ECG signal, improving signal quality. The new sales group consists of independent distributor reps for cardiac rhythm management products. The initial focus will be on the Southern region of the U.S., from North Carolina to Texas; additional representation is already under consideration in other areas of the country. Signalife will start with 25 sales reps and may increase that to 50 by the end of the year. The independent reps will go after their existing relationships with physicians and hospitals, a group that Signalife CEO Pamela Bunes says “mirror the desired call points for our company.”
